Mauricio Contreras@mpcontreras.bsky.socialHere’s the major plot twist… AVRcap1b does not interact with resting-state NRCs but interacts specifically with the active form! It binds NRCs through a surface distinct from the NbTOL9a interface, suggesting it bridges these pathways to “block” immune signaling.
12/15
